These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31303646)

  • 1. Response to Veenstra et al.
    Lacaze P; Tiller J; Bao Y; Riaz M; Winship I; Zhang L
    Genet Med; 2019 Dec; 21(12):2842-2843. PubMed ID: 31303646
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness of population genomic screening.
    Veenstra DL; Guzauskas G; Peterson J; Hassen DA; Snyder S; Hao J; Williams M
    Genet Med; 2019 Dec; 21(12):2840-2841. PubMed ID: 31303645
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Meckley LM, Veenstra DL. Screening for the alpha-adducin Gly460Trp variant in hypertensive patients: a cost-effectiveness analysis. Pharmacogenet Genom 2006; 16:139-147.
    Gerhard T; Beitelshees AL; Johnson JA
    Pharmacogenet Genomics; 2006 Aug; 16(8):613. PubMed ID: 16847430
    [No Abstract]   [Full Text] [Related]  

  • 4. Freshwater monitoring by nanopore sequencing.
    Urban L; Holzer A; Baronas JJ; Hall MB; Braeuninger-Weimer P; Scherm MJ; Kunz DJ; Perera SN; Martin-Herranz DE; Tipper ET; Salter SJ; Stammnitz MR
    Elife; 2021 Jan; 10():. PubMed ID: 33461660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety of plasma-derived haemophilia factor concentrates - comments on "Deep viral metagenomics in patients with haemophilia receiving plasma-derived coagulation factor concentrates" Nunes Valença I et al. (2021). Deep viral metagenomics in patients with haemophilia receiving plasma-derived coagulation factor concentrates. Haemophilia. https://doi.org/10.1111/hae.14382.
    Farrugia A
    Haemophilia; 2021 Nov; 27(6):e760-e761. PubMed ID: 34455649
    [No Abstract]   [Full Text] [Related]  

  • 6. Life on Phosphite: A Metagenomics Tale.
    Tapia-Torres Y; Olmedo-Álvarez G
    Trends Microbiol; 2018 Mar; 26(3):170-172. PubMed ID: 29402580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metagenomics for Clinical Infectious Disease Diagnostics Steps Closer to Reality.
    Dekker JP
    J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29976592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erratum: Veenstra RG, Flynn R, Kreymborg K, et al. B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality.
    Blood; 2016 Jun; 127(24):3104. PubMed ID: 31265498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reply to Varghese et al.'s response to Wu et al. - "Cost effectiveness analysis of infant pneumococcal vaccination in Malaysia and Hong Kong".
    Wu DB; Lee KK; Lee VW; Hong LW
    Hum Vaccin Immunother; 2016 Oct; 12(10):2681-2684. PubMed ID: 27715474
    [No Abstract]   [Full Text] [Related]  

  • 10. MG-RAST, a Metagenomics Service for Analysis of Microbial Community Structure and Function.
    Keegan KP; Glass EM; Meyer F
    Methods Mol Biol; 2016; 1399():207-33. PubMed ID: 26791506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotype by sequencing: An alternative new method to amplicon metabarcoding and shotgun metagenomics for the assessment of eukaryote biodiversity.
    Piñol J
    Mol Ecol Resour; 2021 May; 21(4):1001-1004. PubMed ID: 33423396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demystifying the RAD fad.
    Puritz JB; Matz MV; Toonen RJ; Weber JN; Bolnick DI; Bird CE
    Mol Ecol; 2014 Dec; 23(24):5937-42. PubMed ID: 25319241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Being more realistic about the public health impact of genomic medicine.
    Hall WD; Mathews R; Morley KI
    PLoS Med; 2010 Oct; 7(10):. PubMed ID: 20967240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qin et al. reply.
    Qin N; Le Chatelier E; Guo J; Prifti E; Li L; Ehrlich SD
    Nature; 2015 Sep; 525(7569):E2-3. PubMed ID: 26381989
    [No Abstract]   [Full Text] [Related]  

  • 15. Population genomic screening of all young adults in a health-care system: a cost-effectiveness analysis.
    Zhang L; Bao Y; Riaz M; Tiller J; Liew D; Zhuang X; Amor DJ; Huq A; Petelin L; Nelson M; James PA; Winship I; McNeil JJ; Lacaze P
    Genet Med; 2019 Sep; 21(9):1958-1968. PubMed ID: 30773532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAD in the realm of next-generation sequencing technologies.
    Rowe HC; Renaut S; Guggisberg A
    Mol Ecol; 2011 Sep; 20(17):3499-502. PubMed ID: 21991593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trade-offs and utility of alternative RADseq methods: reply to Puritz et al.
    Andrews KR; Hohenlohe PA; Miller MR; Hand BK; Seeb JE; Luikart G
    Mol Ecol; 2014 Dec; 23(24):5943-6. PubMed ID: 25319129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comment on Gomez et. al. "Response to article by Wasserman et. al. (2018) 'Modelling the sustained use of the 13-valent pneumococcal conjugate vaccine compared to switching to the 10-valent vaccine in Mexico'".
    Wasserman M; Palacios MG; Grajales AG; Wilson M; McDade C; Farkouh R
    Hum Vaccin Immunother; 2019; 15(3):572-574. PubMed ID: 30657407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unravelling virus community ecology in bats through the integration of metagenomics and community ecology.
    Wille M
    Mol Ecol; 2020 Jan; 29(1):23-25. PubMed ID: 31782201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methodological nuances and pitfalls of benefit-cost analysis: a critique.
    Heal LW; McCaughrin WB; Tines JJ
    Res Dev Disabil; 1989; 10(2):201-12. PubMed ID: 2499019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.